New Delhi: India could join the 26 countries to approve Russia’s Sputnik V COVID-19 vaccine in the next few weeks, RIA news agency cited India’s ambassador to Moscow as saying on Monday.
The trials of the vaccine have been started in small batches by India’s Dr. Reddy’s Laboratories Ltd. The lab had earlier stated that Sputnik V meets the primary safety requirements for phase-2 clinical trials in India.
The mid-stage trial data have been submitted to the drug regulator.
The Lancet medical journal stated that the Russian vaccine is more effective than the Chinese ones, and it has 91.6 per cent success rate.
The Sputnik V can be stored in a fridge unlike Pfizer and Moderna’s vaccines.
In September 2020, Dr. Reddy’s and Russian Direct Investment Fund (RDIF) entered into a partnership to conduct its clinical trials.
Also Read: First Trial: Oxford COVID-19 Vaccine To Be Tested On Children
Bhubaneswar: Odisha government has promoted senior IAS officer Hemant Sharma, currently serving as Principal Secretary…
New Delhi: After the record-breaking success of ‘Pushpa 2: The Rule’, Rashmika Mandanna has her…
Bhubaneswar: Twelve members of Village Water and Sanitation Committees (VWSC) from nine districts of Odisha…
Hyderabad: Bollywood actress Janhvi Kapoor, who is rumoured to be dating Shikhar Pahariya, had once…
Bhubaneswar: In a remarkable stride toward strengthening industrial ecosystem, the Odisha government on Wednesday approved…
Bengaluru: Playing away from home, Odisha FC turned the game on its head to snatch a…
This website uses cookies.
